NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/02/2025
Back to search
Official data from USPTO
THE EMERGING BIOTECH LEADER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THE EMERGING BIOTECH LEADER
ST13
US500000098709935Class
9, 41
Filing
98709935
Registration
8053979
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
12/03/2025
Trademark type
Word
Nice classes
9, 41
Filing date
08/21/2024
Registration date
12/02/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/02/2025
Last transaction
12/03/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
First use anywhere
09/05/2022
First use in commerce
09/05/2022
Drawing code
4
Owner type
16
Owner location
Parsippany, NJ
Examiner
CLARK,ANDREW T
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
SSI Strategy LLC
Representatives
Jason H. Kasner Lerner David LLP
Technical classification
Nice Classes
Class 9Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable podcasts in the field of pharmaceuticalsbiotechnology and life sciences
Class 41
Educational and entertainment servicesproviding podcasts in the field of pharmaceuticalsbiotechnology and life sciences
Publications
History of USPTO decisions and trademark events.
18 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
12/02/2025
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
10/30/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/20/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/20/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/20/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/11/2025
GNFR
FINAL REFUSAL E-MAILED
08/11/2025
CNFR
FINAL REFUSAL WRITTEN
08/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/06/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/06/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/06/2025
GNRT
NON-FINAL ACTION E-MAILED
03/06/2025
CNRT
NON-FINAL ACTION WRITTEN
03/06/2025
DOCK
ASSIGNED TO EXAMINER
02/26/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/21/2024
NWAP
NEW APPLICATION ENTERED
08/21/2024
Continuous trademark protection
Get notified about every new filing that threatens THE EMERGING BIOTECH LEADER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.